Acne vulgar is a long lasting skin disease that occurs when dead skin cells and oil from the skin become clogged with hair follicles or skin pores. Acne vulgaris affects to the areas of skin includes the face, the upper part of the chest, and the back. Severe acne is inflammatory, but acne can also manifest in noninflammatory forms. Acne lesions are commonly known as spot, pimples and blemishes.
The major driving factor for the global acne vulgaris treatmentmarket is rapidly growing population of the world and increasing number of
teenagers suffering from skin disease. Acne is the most common skin disorder in
the U.S. hence, it expected to drive the growth in North America region. The
study includes drivers and restraints for the acne vulgaris treatment market
along with the impact they have on the demand over the forecast period.
Additionally, the report includes the study of opportunities available in the
acne vulgaris treatment market on a global level.
Get Full Detail@ http://www.syndicatemarketresearch.com/market-analysis/acne-vulgaris-treatment-market.html
The report covers forecast and analysis for the acne vulgaris
treatment market on a global and regional level. The report also offers
detailed competitive landscape of the global acne vulgaris treatment market.
The report provides detailed segmentation of the acne vulgaris treatment market
based on treatment segment and region.
The Treatment segment segmented into therapeutics and other
treatment. Therapeutics segment is further bifurcated into as antibiotics
(erythromycin and clindamycin), retinoid (adapalene, tazaroteen, tretinoin and
isotretinoin), combination medications, anti-inflammatory, hormonal agents and
other agents (azelaic acid and resorcinol). Other treatment includes laser and
light therapy, cosmetic procedures and acne scar treatments. Therapeutics
accounted for largest segment for acne vulgaris treatment market and expected
to be significant growth over the forecast period.
Get Request Sample@ http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=50879
The report aims to provide a comprehensive overview of market
data and trends in North America, Europe, Asia Pacific, Latin America, and
Middle East & Africa with its further bifurcation of region on the country
level, which includes U.S., Germany, UK, France, China, Japan and India. Among
the all region, North America was dominated the acne vulgaris treatment market
and expected to exhibit strong growth over the forecast period. Europe
accounted for significant share for acne vulgaris treatment market.
Some of the key players in the acne vulgaris treatment market includes Galderma S.A., Hygeia Laboratories Inc., Allergan, Stiefel
Laboratories, Inc. Bayer AG, Cipher, Johnson & Johnson Private Limited and
Valeant Pharmaceutical International Inc.
Acne Vulgaris Treatment Market: Treatment Segment Analysis
- Therapeutics
- Retinoid
(Adapalene, Tazaroteen, Tretinoin and Isotretinoin)
- Antibiotics
(Erythromycin and Clindamycin)
- Hormonal
agents, combination medications, anti-inflammatory
- other
agents (Azelaic acid and Resorcinol)
- Others
(laser & light therapy, cosmetic procedures acne scar
treatments)
Acne Vulgaris Treatment Market: Regional Segment Analysis
- North
America
- U.S.
- Europe
- UK
- France
- Germany
- Asia
Pacific
- China
- Japan
- India
- Latin
America
- Brazil
- Middle
East & Africa
Contact US:
No comments:
Post a Comment